MEI Pharma Inc

Market cap: $20,321,714

Exchange: NAS

Sector: Health Technology

Share
Tweet

MEI Pharma, Inc. is a pharmaceutical company, which engages in the clinical development of therapies for cancer. Its drug candidates include Pracinostat, an oral HDAC inhibitor that is being developed in combination with azacitidine for the treatment of acute myeloid leukemia and myelodysplastic syndrome. Its pipeline also consists of ME-401, an oral PI3K delta inhibitor; Voruciclib, an oral CDK inhibitor; and ME-344, a mitochondrial inhibitor. The company was founded on December 1, 2000 and is headquartered in San Diego, CA.

Key Statistics

Company Name

MEI Pharma Inc

Average Volume (10 days)

11,743

Average Volume (30 days)

17,928

Moving Average (50 days)

$3.65

Moving Average (200 days)

$4.7

Ex-Divided Date

n/a

Dividend Yield

0

P/E Ratio

1.0241

Market Cap

20,321,714

Shares Outstanding

6,662,857

52-Week High Split Adjust Only

6.91

52-Week Low Split Adjust Only

2.88

Employee Count

127

Beta

-0.2264

Next Earnings Date

2024-05-09

TTM Dividend Rate Per Share

0

Price Changes

Past 5 days

-0.06%

Past 30 days

-0.21%

Past 3 months

-0.33%

Past 6 months

-0.27%

Past year

0.05%

Past 2 years

-0.52%

Past 5 years

-0.92%

Max % Change

0%

PEER GROUP COMPARATIVE PERFORMANCE

NameTickerPrice/Sales (ttm)Price/Book (ttm)Forward P/EPEG RatioEV/Revenue
MEI Pharma IncMEIP7.707.01-5.67.703.68
Peer AvgN/A21.312.3530.721.3118.77
Array Technologies IncARRYn/an/a37.6n/an/a
Ligand Pharmaceuticals, Inc. - Class BLGND9.402.6319.19.409.49
XOMA CorpXOMA11.973.02186.711.979.21
Galectin Therapeutics IncGALTn/an/a6.5n/an/a
Curis IncCRIS127.7910.81-32.0127.79112.71
Onconova Therapeutics IncONTXn/an/an/an/an/a
Cyclacel Pharmaceuticals IncCYCCn/an/a-3.4n/an/a